5395242026-09-08Disclosure35395242026-09-08Disclosure25395242026-09-08Disclosure15395242026-09-08xbrli:sharesxbrli:pureiso4217:INR

Prohibition of Insider Trading


DR. LAL PATHLABS LIMITED

General information about company

Scrip Code539524
NSE SymbolLALPATHLAB
MSEI SymbolNOTLISTED
Name of the SignatoryVINAY GUJRAL
Designation of SignatoryCompany Secretary and Compliance Officer
PlaceGURUGRAM
Date of Filing08-09-2026
ISIN CodeINE600L01024
Disclosure under RegulationRegulation 7 (2)
Revised FilingNo

PIT Disclosure

Sr. No.Type of instrumentDescription of type of instrument (applicable in case of other is selected)Category of personName of the personCIN / DINSecurities held prior to acquisition / disposalSecurities acquired / disposedSecurities held post acquisition / disposalDate of allotment advice / acquisition of shares / sale of shares specifyMode of acquisition / disposalDate of intimation to companyType of contractContract specificationBuySellExchange on which the trade was executedNotes
No. of security% of shareholdingNo. of securityValue of security (in Rs.)Transaction typeNo. of security% of shareholdingFrom dateTo dateNotional valueNo. of units (contracts × lot size)Notional valueNo. of units (contracts × lot size)
1EquityDesignated PersonSanjay Kulshreshtha45000.00%500967,252.00Sell40000.00%26-08-202626-08-2026Market Sale07-09-2026NSE
2EquityDesignated PersonSanjay Kulshreshtha40000.00%500712,860.00Buy45000.00%04-09-202604-09-2026ESOP07-09-2026NATextual Information(1)
3EquityOtherDr. Lal PathLabs Employee Welfare Trust7042860.42%30003,198,900.00Sell7012860.42%04-09-202608-09-2026ESOP08-09-2026NATextual Information(2)

Text Block

Textual Information(1)It may be kindly noted that shares were acquired at effective Exercise price (Post Bonus Issue- 2025) of INR 1425.715/- per share under Company’s ESOP Plan
Textual Information(2)It may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of 965.025/-,1087.47/- & 1425.715/- per share (as the case may be) under Company’s ESOP plan(s).